Nature:最快肺结核诊断技术问世

2014-07-08 佚名 科学网

一种便宜的便携诊断系统可以将辨识肺结核(TB)细菌的时间从几周乃至数月缩减至不足半小时,从而有望帮助医生赶在病人不知不觉将这种疾病传染给他人之前对其展开治疗。 美国加利福尼亚州斯坦福大学流行病学家Jason Andrews指出,导致TB的细菌——结核分枝杆菌——在实验室中生长得非常缓慢,因此临床医生鲜有选择来确诊这种传染病。他们要么尝试着从一个样本中培养细菌——这大约需要2个月的时间,要么尝试着在

一种便宜的便携诊断系统可以将辨识肺结核(TB)细菌的时间从几周乃至数月缩减至不足半小时,从而有望帮助医生赶在病人不知不觉将这种疾病传染给他人之前对其展开治疗。

美国加利福尼亚州斯坦福大学流行病学家Jason Andrews指出,导致TB的细菌——结核分枝杆菌——在实验室中生长得非常缓慢,因此临床医生鲜有选择来确诊这种传染病。他们要么尝试着从一个样本中培养细菌——这大约需要2个月的时间,要么尝试着在涂抹于一块载玻片上的痰液样本中寻找这种细菌,而这种技术每次大约会漏掉一半的传染病细菌。

由加利福尼亚州森尼维尔市希菲尔德公司研制的一种名为GeneXpert的方法——并于2010年得到了世界卫生组织(WHO)的大力支持,能够在两三个小时内准确测定结核分枝杆菌的脱氧核糖核酸(DNA),但这种方法需要专门的设备以及人员培训,因此对于农村地区或发展中国家而言有些不切实际。

为了加速这一过程,斯坦福大学化学家Jianghong Rao与得克萨斯农工大学健康科学中心微生物学家Jeffrey Cirillo研制了一种名为CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。研究人员发现,利用这种方法,他们在1毫升样本中便可以检测到10个细菌。

研究人员随后利用采自得克萨斯州的50个痰液样本对这种方法进行了测试。结果表明,该方法可以正确识别所有在显微镜下可见的结核分枝杆菌样本,同时还能够识别80%不可见的传染源。在对非TB患者进行测试时,CDG-3探针的诊断准确率达到了73%。研究人员在7月3日的德国《应用化学》网络版上报告了这一研究成果。

新泽西州纽瓦克市罗格斯大学传染病专家David Alland表示,尽管这项测试有着令人印象深刻的敏感性,但健康人有27%的几率被误诊为TB的事实意味着它将成为一种最有用的分诊方法。例如,在一些偏远的山村,这种方法可以用来排除那些不需要治疗的人们,以便为剩下的人用更昂贵和精确的方法——例如GeneXpert——进行更进一步的临床测试创造条件。在2013年发布的一项研究结果中,Alland及其同事通过计算得出,一套假设的分诊系统能够削减30%到40%的开销。

Rao和Cirillo如今正在与得克萨斯州的诊断公司GBDbio合作,开发一种靠电池供电的便携装置。该装置将能够识别CDG-3被分解时发出的荧光。该公司首席执行官Michael Norman表示,他们希望能够在2015年完成研制工作并顺利上市。他预测,一次单项测试将花费5美元,并且用不了30分钟便能够给出诊断结果。

阿尔伯克基市新墨西哥大学毒理学家Graham Timmins说:“这里为更快速的分诊测试留下了许多空间。”他指出,从健康的角度而言,假阴性(导致感染者被送回家)比假阳性(这会使健康人接受不必要的治疗)更令人担忧——尽管过度使用抗生素会导致耐药性。他称赞这篇论文实现了从实验室到临床的“巨大飞跃”,但他同时表示,该项技术还需要对更加广泛的人群进行测试。

Rao和Cirillo表示,他们正在确认CDG-3的测试结果,并且在更大的人群中进行试验,其中包括一些发展中国家。肺结核是由结核分枝杆菌引起的慢性传染病,可侵及许多脏器,以肺部结核感染最为常见。排菌者为其重要的传染源。人体感染结核菌后不一定发病,当抵抗力降低或细胞介导的变态反应增高时,才可能引起临床发病。若能及时诊断,并予合理治疗,大多可获临床痊愈。

原始出处:

Sara Reardon. Cheap test slashes time taken to diagnose TB. Nature, 3 July 2014;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2015-04-05 fengcongzhilei

    是什么时候可在我国试点

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-09-06 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-08-21 xiongyl1207

    CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。
    CDG-3 期待尽早应用于临床,推荐人类贡献奖!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-26 Lxr4709

    这种方法太好了,希望能早日用到。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-08 222.35.76.19

    什么时候我们能用上?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=19530, encodeId=5459195306f, content=是什么时候可在我国试点, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0a31620495, createdName=fengcongzhilei, createdTime=Sun Apr 05 14:46:00 CST 2015, time=2015-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969220, encodeId=c53e1969220f9, content=<a href='/topic/show?id=b2d0916115f' target=_blank style='color:#2F92EE;'>#诊断技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91611, encryptionId=b2d0916115f, topicName=诊断技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Thu Sep 18 23:47:00 CST 2014, time=2014-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1880162, encodeId=4e9c18801621d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Sep 06 10:47:00 CST 2014, time=2014-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11214, encodeId=2b6211214d7, content=CDG-3的化学制品,这种化合物在被结核分枝杆菌的一种名为BlaC的酶分解后便会发光。在1毫升样本中便可以检测到10个细菌。 <br> CDG-3 期待尽早应用于临床,推荐人类贡献奖!, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b12498217, createdName=xiongyl1207, createdTime=Thu Aug 21 22:26:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10646, encodeId=c5bf1064608, content=这种方法太好了,希望能早日用到。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f8106391, createdName=Lxr4709, createdTime=Sat Jul 26 12:57:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253924, encodeId=3911125392481, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Jul 10 00:47:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10364, encodeId=442e1036479, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10365, encodeId=45cf103653a, content=什么时候我们能用上?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.35.76.19, createdTime=Tue Jul 08 19:49:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-08 222.35.76.19

    什么时候我们能用上?

    0

相关资讯

NEJM:防治肺结核仍需探讨更优方案

潜伏性肺结核感染患者是潜在的巨大传染源,是结核病防治的难题。哈佛大学公共卫生学院免疫学和传染病学系Rubin博士对此展开述评,在线发表于2014年1月23日的The New England Journal of Medicine上。预防肺结核有多种途径,活动性肺结核患者是其传播的主要机制,因此对这部分患者的治疗是预防的关键。但大量的潜伏性肺结核患者也为结核病防治制造了棘手问题,对该部分人群应采用异

Lancet发布“世界防治肺结核日”专刊

3月24日是世界肺结核日,肺结核每年导致200万人死亡,传染的途径主要是患有肺结核的人在咳嗽、打喷嚏或说话的时候喷出结核菌,其他的人从空气中吸入这些结核菌。 医学类顶级期刊Lancet发布肺结核研究防治专刊,其中收集了综述,评论,以及研究成果系列文章,希望借此提高大家对于结核病的关注。 这一专刊探讨了多个方面的问题,包括极度耐药性肺结核,肺结核研究的重点方向,以及目前面临的挑战: • 肺结核

Lancet:中国肺结核发病率20年间减半

一篇新的研究报告表示,由于广泛实施了世界卫生组织(World Health Organization)支持的控制策略,自1990年以来,中国已将肺结核患病率降低了一半以上。医学杂志《柳叶刀》The Lancet上周发表的文章称,肺结核患病率已经从1990年的每10万人170例,降低到了2010年的每10万人59例。 作者对一种称为“短期直接观察治疗方案”,简称DOTS的策略提出了赞扬。从大规模的

中国肺结核发病率大幅下降

肺结核是全球死亡人数最多的传染病,每年夺走多达 140 万人的生命。中国是肺结核主要发病国,其发病率占全球的 1/10 以上。 新的数据显示,过去20多年,中国的肺结核发病率几乎下降了三分之二,由原先的每10万人中有170病例降至59病例。来自中国疾病防控中心的科学家在《柳叶刀》发表评论称,这主要是因为中国加大了对农村地区肺结核控制的投资,同时加大了以社区为主的疾病防控范围。此外,世界卫生组织(

山东25县试点重点人群肺结核筛查

山东省卫生计生委近日印发通知,确定在17个市的25个县(市、区)开展重点人群肺结核筛查试点,使老年人(65岁及以上)及高血压、糖尿病患者肺结核可疑症状筛查率达85%以上。 该省要求,试点地区要将结核病防治纳入当地基本公共卫生服务项目健康教育内容。基层医疗卫生机构在组织健康体检时,对老年人及高血压、糖尿病患者进行肺结核可疑症状问诊,对发现的可疑症状者或影像学检查可疑者,转诊到县级结防机构进行检查

Lancet Respir Med:全球耐药肺结核防治(综述)

广泛耐药性肺结核主要影响从事经济活动的年轻人,具有较高的死亡率,其出现引发了全球的健康危机。在一些国家,如南非, 耐药性肺结核占肺结核病例的3%,却消耗了全国肺结核总预算的1/3以上,该不可持续状况给国家肺结核规划的稳定性带来威胁。然而,谈耐多药结核病色变,特别是完全耐药肺结核和极度耐药肺结核,这两种肺结核耐所有或几乎所有的传统一线和二线抗结核药物。在本综述中,作者讨论了肺结核的流行